Fischell Department of Bioengineering, University of Maryland, College Park, Maryland, USA.
Tissue Eng Part A. 2010 Jan;16(1):55-65. doi: 10.1089/ten.TEA.2009.0027.
We have incorporated hydroxyapatite nanoparticles within cyclic acetal hydrogels to create nanocomposites that can be used to repair surgically created orbital floor defects in a rabbit animal model. Nanosized hydroxyapatite particles may improve tissue engineering scaffold properties because they have similar length scale of many cellular and molecular components and therefore can enhance cellular adhesion and migration. We hypothesize that inclusion of nanosized hydroxyapatite particles (20-70 nm) within cyclic acetal hydrogels would support bone defect repair. The objectives of our study include (1) characterization of nanocomposites in vitro, (2) investigation of tissue response and capsule tissue surrounding nanocomposites in vivo, and (3) investigation of the potential of nanocomposites to facilitate bone formation at 7- and 28-day time points in vivo. Experimental nanocomposite groups consisted of 0, 10, and 50 ng/mL nanosized hydroxyapatite. In vitro results indicated uniform dispersion of nanoparticles within nanocomposites and increased compressive moduli of nanocomposites with increase in nanoparticle concentration and bone marrow stromal cell viability within nanocomposites. In vivo results at day 7 indicated a tissue response of mild to increased inflammatory cells and presence of immature fibrous tissue. At day 28, tissue response consisted of mild inflammatory response and mature tissue. Quantitative results at day 7 indicated no difference in total bone percentage area between groups. The results also indicated that the tissue capsule surrounding the 0, 10, and 50 ng group implants had no clear organization. Quantitative results at day 28 indicated that the tissue capsule surrounding the 0, 10, and 50 ng group implants was an organized layer and the bone percentage for the 50 ng group was significantly higher than that of the remaining groups. Initial results indicated that our nanocomposites initiate a positive in vivo response in terms of bone growth. However, the percentage of bone area compared with the total area was low at both time points. Thus, in our study, even after addition of nanoparticles to cyclic acetal hydrogels, their biocompatible properties were maintained. On the other hand, addition of nanoparticles to cyclic acetal hydrogels did not lead to complete restoration of orbital floor defects.
我们将羟基磷灰石纳米粒子纳入环状缩醛水凝胶中,以创建纳米复合材料,可用于修复兔动物模型中经手术创建的眶底缺陷。纳米级羟基磷灰石颗粒可以改善组织工程支架的性能,因为它们与许多细胞和分子成分的长度尺度相似,因此可以增强细胞黏附和迁移。我们假设,在环状缩醛水凝胶中加入纳米级羟基磷灰石颗粒(20-70nm)将有助于骨缺损的修复。我们研究的目的包括:(1)体外对纳米复合材料进行表征;(2)研究体内纳米复合材料的组织反应和胶囊组织;(3)研究纳米复合材料在 7 天和 28 天体内时间点促进骨形成的潜力。实验性纳米复合材料组由 0、10 和 50ng/ml 的纳米级羟基磷灰石组成。体外结果表明纳米颗粒在纳米复合材料中的均匀分散,以及纳米复合材料的压缩模量随着纳米颗粒浓度的增加和纳米复合材料中骨髓基质细胞的活力而增加。在第 7 天的体内结果表明,组织反应为轻度至中度炎症细胞增加,并存在未成熟的纤维组织。在第 28 天,组织反应由轻度炎症反应和成熟组织组成。第 7 天的定量结果表明,各组间总骨百分比面积无差异。结果还表明,0、10 和 50ng 组植入物周围的组织胶囊没有明确的组织。第 28 天的定量结果表明,0、10 和 50ng 组植入物周围的组织胶囊是一个有组织的层,50ng 组的骨百分比明显高于其余组。初步结果表明,我们的纳米复合材料在骨生长方面引发了体内的阳性反应。然而,在两个时间点,与总面积相比,骨面积的百分比都较低。因此,在我们的研究中,即使在环状缩醛水凝胶中加入纳米粒子,其生物相容性也得以保持。另一方面,将纳米粒子添加到环状缩醛水凝胶中并没有导致眶底缺陷的完全恢复。